Vera Hoffman
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$15.7MFederal grants as PI18 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
18 awards · $15.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 30, 2024 | NIH | SBIR Phase II Fibrogenesis Targeted Manganese Based MRI Contrast Agent | $969K | — |
| May 21, 2024 | NIH | SBIR Phase II Manganese Based MRI Contrast Agent | $2.0M | — |
| May 1, 2024 | NIH | SBIR Phase II Manganese-based Contrast Agent for Cardiovascular MRI | $1.0M | — |
| Jul 31, 2023 | NIH | SBIR Phase II Fibrogenesis Targeted Manganese Based MRI Contrast Agent | $980K | — |
| Jun 6, 2023 | NIH | SBIR Phase II Manganese Based MRI Contrast Agent | $2.0M | — |
| May 23, 2023 | NIH | SBIR Phase II Manganese-based Contrast Agent for Cardiovascular MRI | $1.0M | — |
| Sep 15, 2022 | NIH | SBIR Phase II Fibrogenesis Targeted Manganese Based MRI Contrast Agent | $290K | — |
| Aug 5, 2022 | NIH | SBIR Phase II Manganese Based MRI Contrast Agent - First In Human Clinical Trial | $904K | — |
| Sep 24, 2021 | NIH | SBIR Phase II Manganese Based MRI Contrast Agent - First In Human Clinical Trial | $1.1M | — |
| Aug 18, 2021 | NIH | SBIR Phase II Liver Specific Manganese Based MRI Contrast Agent | $999K | — |
| Dec 11, 2020 | NIH | SBIR Phase I Manganese-based Contrast Agent for Cardiovascular MRI | $300K | — |
| Aug 26, 2020 | NIH | SBIR Phase II Liver Specific Manganese Based MRI Contrast Agent | $996K | — |
| Jun 4, 2020 | NIH | SBIR Phase II Manganese based MRI contrast agent | $1000K | — |
| Aug 8, 2019 | NIH | SBIR Phase II Liver Specific Manganese Based MRI Contrast Agent | $300K | — |
| Apr 2, 2019 | NIH | SBIR Phase II Manganese based MRI contrast agent | $706K | — |
| Sep 20, 2018 | NIH | SBIR Phase II Manganese based MRI contrast agent | $163K | — |
| May 16, 2018 | NIH | SBIR Phase II Manganese based MRI contrast agent | $666K | — |
| May 11, 2017 | NIH | SBIR Phase II Manganese based MRI contrast agent | $210K | — |
Peer ranks
Federal funding#7
Awards as PI#18
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.